Gilead Sciences, Inc. wanted to develop a strategy to reach young people with the important message about getting tested for STDs, including HIV.

Emory University and Gilead Sciences, Inc. asked GA to assist with the communications and marketing for AIDSVu, an online tool that aims to make HIV prevalence data widely accessible and locally relevant.

GA’s efforts for Insmed centered on enhancing the company’s visibility on Wall Street and establishing Insmed as a biotech market leader in advance of the development of an FDA approval pathway for follow-on biologics, or biogenerics.

Despite decades of prevention campaigns, HIV continues to spread in the U.S. In some areas like Washington, D.C., the infection rates rival those seen in the most impoverished nations in Africa where AIDS is a full-blown epidemic. GA, having worked with Gilead Sciences for many years, saw this trend as an opportunity to drive change: what if we could map the disease, county by county, across the country, and help pinpoint where preventative treatment and education might make the biggest impact in stemming the spread of HIV?